Table 2.
Admission laboratory findings of the study patients with and without contrast-induced nephropathy
| Variables | CIN (+) (n = 95) | CIN (−) (n = 778) | P value |
|---|---|---|---|
| Basal creatinine, mg/dL | 1.47 ± 0.94 | 1.06 ± 0.71 | <0.001 |
| Postprocedural creatinine, mg/dL | 2.64 ± 1.23 | 1.08 ± 0.73 | <0.001 |
| eGFR, mL/min/1.73 m2 | 56.1 ± 27.6 | 81.7 ± 27.4 | <0.001 |
| Glucose on admission, mg/dL | 162.9 ± 98.3 | 127.3 ± 66.3 | 0.004 |
| Hemoglobin, g/dL | 12.48 ± 2.12 | 13.58 ± 1.88 | <0.001 |
| Total cholesterol, mg/dL | 170.9 ± 44.5 | 184.4 ± 41.2 | <0.001 |
| Triglyceride, mg/dL | 163.3 ± 106.1 | 158.9 ± 86.4 | 0.983 |
| HDL cholesterol, mg/dL | 36.4 ± 10.1 | 38.2 ± 8.9 | 0.012 |
| LDL cholesterol, mg/dL | 130.9 ± 28.1 | 132.5 ± 29.6 | 0.708 |
| Monocyte count (/mm3), median (IQR) | 0.64 (0.44–0.95) | 0.61 (0.44–0.80) | 0.161 |
| Lymphocyte count (/mm3), median(IQR) | 1.66 (1.21–2.33) | 1.86 (1.34–2.43) | 0.302 |
| Neutrophil count (/mm3), median (IQR) | 7.67 (5.45–11.1) | 6.99 (4.92–9.66) | 0.030 |
| Platelet count (× 109/L), median (IQR) | 231 (188–281) | 237.5 (204–290) | 0.211 |
| Mean platelet volume, fL, median (IQR) | 9.4 (8.4–10.5) | 8.7 (7.7–9.9) | <0.001 |
| Lymphocyte-to-monocyte ratio | 2.42 (1.67–3.49) | 3.25 (2.40–4.99) | <0.001 |
| Neutrophil-to-lymphocyte ratio | 3.99 (2.88–7.52) | 3.79 (2.24–6.06) | 0.055 |
| Platelet-to-lymphocyte ratio | 135.3 (92.1–216.7) | 130.1 (96.1–192.7) | 0.897 |
CIN: contrast-induced nephropathy; eGFR: estimated glomerular filtration rate; HDL: high-density lipoprotein; IQR: interquartile range; LDL: low-density lipoprotein.